Skip to main content
Premium Trial:

Request an Annual Quote

Sirna Therapeutics, UC Davis, CombiMatrix

Premium

Sirna Seeks Director of Alliance Management

Sirna Therapeutics has begun looking for a director of alliance management, a position that will be based out of its San Francisco headquarters, according to the company's website.

The director "will be instrumental in maintaining successful alliances between Sirna and its industry, government, academic partners, and collaborators, as well as function as the senior customer advocate within Sirna," the company said. "The position will establish account management strategies, design and implement account management functions and will manage the operational, technical and financial aspects of Sirna's alliances."

Sirna President and CEO Howard Robin noted at the recent JPMorgan Healthcare Conference in San Francisco that the company anticipates signing one major partnership with a big pharma during 2006 (see RNAi News, 1/19/2006).

The director of alliance management will report to Sirna's senior vice president of corporate development, Michael French.


UC Davis Joins CombiMatrix's Core Access Program

The University of California, Davis, has joined CombiMatrix's CombiCore access program, Combi parent Acacia Research said this week.

Under the non-exclusive agreement, all UC Davis researchers can purchase, through the UC Davis Genome Center, CombiMatrix's CustomArrays and CatalogArrays, including array processing services performed at the UC Davis Genome Center.

Financial details were not disclosed.

This is the second university CombiMatrix has signed on to its CombiCore program, which the company initiated this quarter. Earlier this month it signed an agreement with the University of Colorado.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.